A specialty pharmaceutical company focused on drug delivery technologies designed to improve the effectiveness and safety of existing medications. The firm developed and licensed formulation platforms used by pharmaceutical partners to enhance bioavailability and control drug release. Investors hist...
2 members of Congress have disclosed 2 trades in Eurand N.V. Corp Common Stock (EURX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2012-08-14 | Matt Cartwright | sell | $15K – $50K |
| 2012-08-04 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $15K – $50K |